Stay updated on Pralsetinib in RET+ Cancer Clinical Trial

Sign up to get notified when there's something new on the Pralsetinib in RET+ Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pralsetinib in RET+ Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This indicates a minor update to the page version and routine maintenance rather than any visible content change.
    Difference
    0.0%
    Check dated 2026-09-01T18:07:01.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new line '2016 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, recording NIH funding information. This addition provides funding attribution for the ARROW trial within the study record.
    Difference
    0.0%
    Check dated 2026-08-25T16:41:27.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.4 to v3.6.5, indicating a software update.
    Difference
    0.0%
    Check dated 2026-08-11T08:23:13.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, signaling a recent software release update for the page. This is an internal update rather than a change to study data or content.
    Difference
    0.0%
    Check dated 2026-07-28T03:06:31.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The revision badge at the bottom of the page updated from v3.6.2 to v3.6.3, indicating a minor update to the entry.
    Difference
    0.0%
    Check dated 2026-07-06T15:55:06.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.6.2, replacing the prior Revision: v3.6.0; the change represents a small system update rather than a modification to study data or page functionality.
    Difference
    0.0%
    Check dated 2026-06-29T08:37:16.000Z thumbnail image

Stay in the know with updates to Pralsetinib in RET+ Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pralsetinib in RET+ Cancer Clinical Trial page.